Current heart failure (HF) risk prediction models do not consider how individual patient assessments occur in incremental steps; furthermore, each additional diagnostic evaluation may add cost, complexity, and potential morbidity
AIMS: The aim of this study was to generate a biomarker-driven prognostic tool for patients with chr...
AimsWe aimed to develop a risk prediction tool that incorporated both clinical events and worsening ...
Introduction: From a prospective multicentre multicountry clinical trial, we developed and valid...
International audienceBACKGROUND:Current heart failure (HF) risk prediction models do not consider h...
Background: The prediction of outcomes in patients with heart failure (HF) may inform prognosis, cli...
Refer to the page 659-667 Heart failure (HF) is a common clinical syndrome with high mor-bidity and ...
Aims: The aim of this study was to generate a biomarker-driven prognostic tool for patients with chr...
Aims: In recent years there has been an increase in the number of biomarkers in heart failure ( HF )...
International audienceAbstract Aims The aim of this study was to generate a biomarker-driven prognos...
© 2015 Dr. Jennifer CollerFull text embargoed until: 2022-10-21The development of symptomatic heart ...
Importance: Accurate prediction of risk of death or hospitalizations in patients with heart failure...
Background: The Seattle heart failure model or the cardiac and comorbid conditions (3C-HF) scores ma...
Importance: Heart failure (HF) treatment recommendations are centered on New York Heart Association ...
A simple and effective heart failure (HF) risk score would facilitate the primary prevention and ear...
OBJECTIVES: This study compared the performance of major heart failure (HF) risk models in predi...
AIMS: The aim of this study was to generate a biomarker-driven prognostic tool for patients with chr...
AimsWe aimed to develop a risk prediction tool that incorporated both clinical events and worsening ...
Introduction: From a prospective multicentre multicountry clinical trial, we developed and valid...
International audienceBACKGROUND:Current heart failure (HF) risk prediction models do not consider h...
Background: The prediction of outcomes in patients with heart failure (HF) may inform prognosis, cli...
Refer to the page 659-667 Heart failure (HF) is a common clinical syndrome with high mor-bidity and ...
Aims: The aim of this study was to generate a biomarker-driven prognostic tool for patients with chr...
Aims: In recent years there has been an increase in the number of biomarkers in heart failure ( HF )...
International audienceAbstract Aims The aim of this study was to generate a biomarker-driven prognos...
© 2015 Dr. Jennifer CollerFull text embargoed until: 2022-10-21The development of symptomatic heart ...
Importance: Accurate prediction of risk of death or hospitalizations in patients with heart failure...
Background: The Seattle heart failure model or the cardiac and comorbid conditions (3C-HF) scores ma...
Importance: Heart failure (HF) treatment recommendations are centered on New York Heart Association ...
A simple and effective heart failure (HF) risk score would facilitate the primary prevention and ear...
OBJECTIVES: This study compared the performance of major heart failure (HF) risk models in predi...
AIMS: The aim of this study was to generate a biomarker-driven prognostic tool for patients with chr...
AimsWe aimed to develop a risk prediction tool that incorporated both clinical events and worsening ...
Introduction: From a prospective multicentre multicountry clinical trial, we developed and valid...